Press Releases

• Actithera: Secures Exclusive Rights to Innovative Covalent Chemistry Technologies From Weizmann Institute for Targeted Radiopharmaceutical Applications More
• Akamis Bio: Receives FDA Fast Track Designation for NG-350A for the Treatment of Mismatch Repair-Proficient Locally Advanced Rectal Cancer More
• Alzheon: Peer-Reviewed Scientific Publication of Results From Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in APOE4/4 Homozygous Individuals With Early Alzheimer’s Disease More  
• Biogen: LEQEMBI IQLIK(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s "Best Inventions of 2025" More
• BPGbio: Welcomes Sheikh Dr. Khalid Bin Jabor Al Thani as Executive in Residence More
• Candel Therapeutics: Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine More
• Revvity: Showcases Progress With Purpose in 2025 Impact Report More

Financial News

• AI Biotech Startup Signs 235K SF Alewife Lease: The Boston Deal Sheet More*
• Apogee Therapeutics: Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million More
• BioCryst: Will Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile More 
  
• BYTE51: Exclusive Pricing on Private Biotech & VC Intelligence More
• Candel Therapeutics: Enters Into $130 Million Term Loan Facility With Trinity Capital Inc. More
• Fulcrum Therapeutics: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More
• Kailera Therapeutics: $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity More More* More*
• Major Mass. Biomanufacturer Closes 2nd Site, Lays Off More Workers More*
• More on Bristol’s $1.5B Orbital Buyout Extending 'In Vivo' Cell Therapy Deal Streak More More*
• Nabla Bio: Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics More More More*
• Spyre Therapeutics: Pricing of $275.0 Million Public Offering of Common Stock More
• Stellaromics: Installation of First Pyxa 3D Spatial Transcriptomics System at the University of Glasgow More

Media/Misc Coverage

• Moderna Previews Cancer Antigen Therapy in Melanoma Ahead of ESMO More* More
• Reflecting on LabCentral’s AI BioHub: Lessons From the Inaugural Cohort More
• Subscribe to LifeSci Startup for Updates on US Startups More

Companies

Career Center

• BBJ’s Women Who Lead in Life Sciences Offer Career Advice in Tough Times More*
• CEO’s Perspective: Big Moves Come with Big Responsibility More
• CEO’s Perspective: The High Cost of Job Hopping More
• ICYMI: The Power of Peer Learning - Why Even Top Biotech Leaders Need Mentorship More
• Shape’s Former CSO Picks Up Tech Role at Moderna; Lilly Reels In Peter Marks More*
• What’s Next in Precision Medicine: Leadership Challenges and Opportunities More

• BioFuture Oct 13-15
• Advanced Lateral Flow Conference (ALFC) 2025 Oct 14-15
• BioscienceLA Week Oct 14-17
• Biocom California CEO Summit (San Diego) Oct 15
• In Vivo Study Paths Explained: Pros and Cons from CROs to Private Labs Oct 15
• Biocom California CEO Summit (Bay Area/Wine Country) Oct 24
• 15th Annual PODD Conference Oct 27-28
• New Jersey Life Sciences & Biotech Conference Oct 28
• Biocom California CEO Summit (Los Angeles) Oct 29
• Meet the Experts | ADME & DMPK Nov 6
• Pantheon 2025 Nov 6
• BIO-Europe 2025 Nov 11-12
• Copay, Reimbursement and Access Congress (Save 10% with VIP code: 25B4B10) Nov 18-20
• Pharma/Biotech Gross-To-Net Summit (Save 10% with VIP code: 25B4B10) Nov 18-20
• Patient Support Services Congress (Save 10% with VIP code: 25B4B10) Nov 20-21
• Compounding Pharmacy Compliance (Save 10% with VIP code: 25B4B10) Dec 9-10
• Trade and Channel Strategies (Save 10% with VIP code: 25B4B10) Dec 9-11
  
• Advancing Drug Development Forum Dec 11

Boston Sponsors